ONKURE THERAPEUTICS, INC. Operating Lease, Expense
ONKURE THERAPEUTICS, INC. (OKUR) reported Operating Lease, Expense of $214.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-07
- ONKURE THERAPEUTICS, INC. operating lease, expense for the quarter ending 2024-09-30 was $66.00K, a 31.96% decline year-over-year.
- ONKURE THERAPEUTICS, INC. operating lease, expense for the quarter ending 2024-06-30 was $65.00K, a 46.28% decline year-over-year.
- ONKURE THERAPEUTICS, INC. operating lease, expense for the quarter ending 2024-03-31 was $83.00K, a 30.83% decline year-over-year.
- ONKURE THERAPEUTICS, INC. operating lease, expense for the quarter ending 2023-12-31 was $62.00K, a 61.73% decline year-over-year.
- ONKURE THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $400.00K, a 20.00% decline from fiscal 2022.
- ONKURE THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $500.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $131.00K derived: sum of 2 quarters · filed 2024-11-07 | $214.00K 10-Q · filed 2024-11-07 | $276.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $148.00K 10-Q · filed 2024-08-13 | $210.00K derived: sum of 3 quarters · filed 2024-08-13 | $307.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-03-31 | $83.00K 10-Q · filed 2024-05-07 | $145.00K derived: sum of 2 quarters · filed 2024-05-07 | $242.00K derived: sum of 3 quarters · filed 2024-11-07 | $363.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $159.00K derived: sum of 2 quarters · filed 2024-11-07 | $280.00K derived: sum of 3 quarters · filed 2024-11-07 | $400.00K 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $218.00K derived: sum of 2 quarters · filed 2024-11-07 | $338.00K 10-Q · filed 2024-11-07 | $354.00K 10-Q · filed 2023-11-13 | $500.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $241.00K 10-Q · filed 2024-08-13 | $403.00K derived: sum of 3 quarters · filed 2024-08-13 | $503.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $120.00K 10-Q · filed 2024-05-07 | $282.00K derived: sum of 2 quarters · filed 2024-05-07 | $382.00K derived: sum of 3 quarters · filed 2024-05-07 | $482.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $262.00K derived: sum of 2 quarters · filed 2024-03-28 | $362.00K derived: sum of 3 quarters · filed 2024-03-28 | $500.00K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-08 | $200.00K derived: sum of 2 quarters · filed 2022-11-08 | $338.00K 10-Q · filed 2023-11-13 | $400.00K 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-09 | $241.00K 10-Q · filed 2023-08-10 | $300.00K 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $122.00K 10-Q · filed 2023-05-11 | |||||
| 2021-03-31 | $46.00M 10-Q · filed 2021-05-20 | |||||
| 2020-03-31 | $46.00M 10-Q · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |